J Cancer Prev.
2025 Mar;30(1):7-11. 10.15430/JCP.24.028.
Therapeutic Strategies for Drug-resistant Melanoma and Their Clinical Implications
- Affiliations
-
- 1Department of Animal Science and Biotechnology, Research Institute for Innovative Animal Sciences, Kyungpook National University, Sangju, Korea
- KMID: 2566786
- DOI: http://doi.org/10.15430/JCP.24.028
Abstract
- Melanoma is a malignant tumor originating from melanocytes, characterized by its high invasiveness and metastasis, leading to poor prognosis and high mortality. Early-stage melanoma is primarily treated with surgery; however, due to its metastatic nature, surgery becomes challenging in advanced stages. Treatment strategies for advanced or metastatic melanoma include chemotherapy, radiation therapy, and targeted therapy. However, melanoma’s propensity for rapid drug resistance remains a significant clinical challenge. This review summarizes the developments in the treatment of drug-resistant melanoma over the past decade and discusses the advantages and disadvantages of various therapeutic approaches and their clinical significance implications.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?
- Clinical Implications of Drug-Resistant Streptococcus pneumoniae as a Cause of Community Acquired Pneumonia
- Pediatric tuberculosis and drug resistance
- Medical Management of Drug-Resistant Tuberculosis
- Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis
